What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?

Ann Oncol. 2008 Sep:19 Suppl 7:vii184-6. doi: 10.1093/annonc/mdn455.

Authors

E C Johnstone¹, D J Kerr

Affiliation

¹ Department of Clinical Pharmacology, Oxford University, Oxford, UK.

PMID: 18790945
DOI: 10.1093/annonc/mdn455

No abstract available

MeSH terms

Biomarkers, Tumor / genetics*
Chemotherapy, Adjuvant
Colorectal Neoplasms / drug therapy*
Colorectal Neoplasms / genetics*
Colorectal Neoplasms / radiotherapy
Colorectal Neoplasms / surgery
Humans
Pharmacogenetics / methods*
Radiotherapy, Adjuvant

Substances

Biomarkers, Tumor